CTC Status Predicts RT Benefit in Early-Stage Breast Cancer

Share this content:
CTC Status Predicts RT Benefit in Early-Stage Breast Cancer
CTC Status Predicts RT Benefit in Early-Stage Breast Cancer

THURSDAY, May 3, 2018 (HealthDay News) -- Circulating tumor cell status is predictive of radiotherapy (RT) benefit in early-stage breast cancer, according to a study published online May 3 in JAMA Oncology.

Chelain R. Goodman, M.D., Ph.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues included data from the National Cancer Database (NCDB; 1,697 patients) and the SUCCESS clinical trial (1,516 patients) to examine whether CTC status is predictive of radiotherapeutic benefit in early-stage breast cancer.

The researchers detected CTCs in 23.5 and 19.4 percent of the NCDB and SUCCESS cohorts, respectively. The correlation of RT with survival was dependent on CTC status in the NCDB cohort; in the SUCCESS cohort, the correlation with disease-free survival was dependent on CTC status. RT correlated with longer OS in patients with CTCs in the NCDB cohort (time ratio [TR], 2.04), but not in patients without CTCs. CTC-positive patients treated with RT had longer local recurrence-free survival, disease-free survival, and overall survival in the SUCCESS cohort (TRs, 2.73, 3.03, and 1.83, respectively). For patients from both cohorts who underwent breast-conserving surgery, RT correlated with longer OS in those with CTCs (TR, 4.37), but not in those without. There was no correlation for RT with overall survival after mastectomy in CTC-positive or CTC-negative patients.

"These results are hypothesis generating; a prospective trial evaluating CTC-based management for RT after breast-conserving surgery in women with early-stage breast cancer is warranted," the authors write.

Abstract/Full Text
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

California Lawsuit Claims AbbVie Paid Doctors to Prescribe Humira

California Lawsuit Claims AbbVie Paid Doctors to Prescribe ...

Claims physicians prescribed Humira because of financial kickbacks, not as best drug for patient

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-controlled remifentanil reduces proportion of conversions versus intramuscular pethidine

Pediatricians Have Role in Supporting Transgender Youth

Pediatricians Have Role in Supporting Transgender Youth

Recommendations developed for comprehensive care for youth identifying as transgender, gender diverse

is free, fast, and customized just for you!




Already a member?

Sign In Now »